RPG LIFE SCIENCES
|
RPG LIFE SCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 |
| CEPS(Rs) | 50.27 | 40.60 | 34.15 | 27.43 | 15.80 |
| DPS(Rs) | 12.00 | 9.60 | 7.20 | 4.00 | 2.40 |
| Book NAV/Share(Rs) | 186.00 | 154.66 | 130.88 | 106.77 | 97.05 |
| Tax Rate(%) | 26.22 | 29.64 | 25.35 | 20.41 | 28.17 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.66 | 18.18 | 16.87 | 15.95 | 10.43 |
| EBIT Margin(%) | 16.73 | 15.55 | 13.20 | 10.44 | 6.03 |
| Pre Tax Margin(%) | 16.53 | 15.26 | 12.77 | 9.71 | 4.56 |
| PAT Margin (%) | 12.19 | 10.74 | 9.53 | 7.72 | 3.27 |
| Cash Profit Margin (%) | 14.98 | 14.00 | 13.46 | 12.08 | 7.91 |
| Performance Ratios | |||||
| ROA(%) | 17.71 | 15.89 | 14.00 | 11.25 | 4.07 |
| ROE(%) | 24.01 | 21.80 | 20.36 | 17.21 | 6.86 |
| ROCE(%) | 32.92 | 31.46 | 27.27 | 20.35 | 9.81 |
| Asset Turnover(x) | 1.45 | 1.48 | 1.47 | 1.46 | 1.24 |
| Sales/Fixed Asset(x) | 2.73 | 2.61 | 2.37 | 2.23 | 2.11 |
| Working Capital/Sales(x) | 3.44 | 3.78 | 4.36 | 8.70 | 17.13 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.37 | 0.38 | 0.42 | 0.45 | 0.47 |
| Receivable days | 23.17 | 34.41 | 52.52 | 49.68 | 59.16 |
| Inventory Days | 58.57 | 53.79 | 45.64 | 42.59 | 52.36 |
| Payable days | 128.38 | 132.94 | 138.23 | 106.09 | 135.21 |
| Valuation Parameters | |||||
| PER(x) | 17.01 | 17.98 | 16.00 | 9.72 | 37.90 |
| PCE(x) | 13.84 | 13.78 | 11.34 | 6.21 | 15.68 |
| Price/Book(x) | 3.74 | 3.62 | 2.96 | 1.60 | 2.55 |
| Yield(%) | 1.72 | 1.72 | 1.86 | 2.35 | 0.97 |
| EV/Net Sales(x) | 2.13 | 1.94 | 1.54 | 0.78 | 1.35 |
| EV/Core EBITDA(x) | 10.10 | 9.48 | 8.36 | 4.80 | 12.64 |
| EV/EBIT(x) | 11.78 | 11.48 | 10.85 | 7.46 | 22.37 |
| EV/CE(x) | 2.61 | 2.48 | 1.98 | 1.09 | 1.80 |
| M Cap / Sales | 2.24 | 2.10 | 1.65 | 0.75 | 1.24 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.51 | 13.11 | 3.61 | 13.75 | -4.01 |
| Core EBITDA Growth(%) | 20.04 | 25.61 | 17.98 | 72.84 | -10.63 |
| EBIT Growth(%) | 24.47 | 34.69 | 41.21 | 96.94 | -20.61 |
| PAT Growth(%) | 31.39 | 28.70 | 37.88 | 168.36 | -19.63 |
| EPS Growth(%) | 31.39 | 28.70 | 37.88 | 168.36 | -19.63 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.01 | 0.07 | 0.23 |
| Current Ratio(x) | 2.57 | 2.58 | 2.21 | 1.52 | 1.25 |
| Quick Ratio(x) | 1.64 | 1.55 | 1.47 | 0.96 | 0.72 |
| Interest Cover(x) | 80.72 | 52.89 | 30.93 | 14.21 | 4.10 |
| Total Debt/Mcap(x) | - | - | - | 0.04 | 0.09 |
Compare Financial Ratios of peers of RPG LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RPG LIFE SCIENCES | ₹2,479.5 Cr | 1.1% | -0.7% | 93.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
| CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics | |
RPG LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RPG LIFE SCIENCES | 1.1% |
-0.7% |
93.7% |
| SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses
